May 2019
- May 1, 2019
- 1 min read
Updated: Jan 8
Synendos Therapeutics was selected among the three finalists at the perfect pitch competition held at the BioTrinity London conference for Europe’s Leading Biopartnering and Investment.
top of page
bottom of page